Clinical Trial Update: To Compare the Efficacy of Combination Therapy vs Monotherapy for Pulmonary Arterial Hypertension in Systemic Sclerosis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating combination therapy versus monotherapy for pulmonary arterial hypertension in systemic sclerosis, with current status not…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension
• Systemic Sclerosis
• Systemic Sclerosis-associated Pulmonary Arterial Hypertension

Snippet

Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh | Conditions: Associated Pulmonary Arterial Hypertension | Phase 4 | Status: UNKNOWN